Extended spectrum beta-lactamase-producing bacteria and Clostridium difficile in patients with pouchitis

Alimentary Pharmacology and Therapeutics

Volumn 32, Issue 5, 2010, Pages 664-669

  McLaughlin, S D ^a,b,c   Clark, S K ^a,b   Roberts, C H ^d   Perry Woodford, Z L ^a   Tekkis, P P ^b   Ciclitira, P J ^c   Nicholls, R J ^b  

^a ST MARK S HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFALEXIN; CEFIXIME; CEFPODOXIME; CIPROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; NITROFURANTOIN; TRIMETHOPRIM;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM IDENTIFICATION; CLINICAL ARTICLE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES ANALYSIS; FEMALE; HUMAN; ILEITIS; MALE; NONHUMAN; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROCTOCOLECTOMY; RISK ASSESSMENT;

ADULT; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; DRUG RESISTANCE; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; POUCHITIS; PROCTOCOLECTOMY, RESTORATIVE; RISK FACTORS; YOUNG ADULT;

EID: 77955170136     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2010.04401.x     Document Type: Article

References (37)

1. McLaughlin SD, Clark SK, Tekkis PP, Ciclitira PJ, Nicholls RJ. Review article: restorative proctocolectomy, indications, management of complications and follow-up: a guide for gastroenterologists. Aliment Pharmacol Ther 2008 27 : 895 909.
2. McLaughlin SD, Clark SK, Bell AJ, et al. Incidence and short-term implications of prepouch ileitis following restorative proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis. Dis Colon Rectum 2009 52 : 879 883.
3. Bell AJ, Price AB, Forbes A, Ciclitira PJ, Groves C, Nicholls RJ. Pre-pouch ileitis: a disease of the ileum in ulcerative colitis after restorative proctocolectomy. Colorectal Dis 2006 8 : 402 410.
4. Mimura T, Rizzello F, Helwig U, et al. Four-week open-label trial of metronidazole and ciprofloxacin for the treatment of recurrent or refractory pouchitis. Aliment Pharmacol Ther 2002 16 : 909 917.
5. Shen B, Achkar JP, Lashner BA, et al. A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis. Inflamm Bowel Dis 2001 7 : 301 305.
6. Shen B, Fazio VW, Remzi FH, et al. Combined ciprofloxacin and tinidazole therapy in the treatment of chronic refractory pouchitis. Dis Colon Rectum 2007 50 : 498 508.
7. Tulchinsky H, Hawley PR, Nicholls J. Long-term failure after restorative proctocolectomy for ulcerative colitis. Ann Surg 2003 238 : 229 234.
8. Shen B, Goldblum JR, Hull TL, et al. Clostridium difficile-associated pouchitis. Dig Dis Sci 2006 51 : 2361 2364.
9. Mann SD, Pitt J, Springall RG, et al. Clostridium difficile infection - an unusual cause of refractory pouchitis: report of a case. Dis Colon Rectum 2003 46 : 267 270.
10. Shen B, Lashner B. Diagnosis and treatment of ileal pouch diseases in patients with underlying ulcerative colitis. Curr Treat Options Gastroenterol 2006 9 : 3 12.
11. Rupp ME, Fey PD. Extended spectrum beta-lactamase (ESBL)-producing enterobacteriaceae: considerations for diagnosis, prevention and drug treatment. Drugs 2003 63 : 353 365.
12. Spanu T, Luzzaro F, Perilli M, et al. Occurrence of extended-spectrum beta-lactamases in members of the family enterobacteriaceae in Italy: implications for resistance to beta-lactams and other antimicrobial drugs. Antimicrob Agents Chemother 2002 46 : 196 202.
13. Paterson DL, Mulazimoglu L, Casellas JM, et al. Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia. Clin Infect Dis 2000 30 : 473 478.
14. Bradford PA. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001 14 : 933 951.
15. Rooney PJ, O'Leary MC, Loughrey AC, et al. Nursing homes as a reservoir of extended-spectrum beta-lactamase (ESBL)-producing ciprofloxacin-resistant Escherichia coli. J Antimicrob Chemother 2009 64 : 635 641.
16. Kader AA, Kumar A, Kamath KA. Fecal carriage of extended-spectrum beta-lactamase-producing escherichia coli and Klebsiella pneumoniae in patients and asymptomatic healthy individuals. Infect Control Hosp Epidemiol 2007 28 : 1114 1116.
17. Friedmann R, Raveh D, Zartzer E, et al. Prospective evaluation of colonization with extended-spectrum beta-lactamase (ESBL)-producing enterobacteriaceae among patients at hospital admission and of subsequent colonization with ESBL-producing enterobacteriaceae among patients during hospitalization. Infect Control Hosp Epidemiol 2009 30 : 534 542.
18. McLaughlin SD, Clark SK, Shafi S, et al. Fecal Coliform Testing to Identify Effective Antibiotic Therapies for Patients With Antibiotic-Resistant Pouchitis. Clin Gastroenterol Hepatol 2009 7 : 545 548.
19. Shen BO, Jiang ZD, Fazio VW, et al. Clostridium difficile infection in patients with ileal pouch-anal anastomosis. Clin Gastroenterol Hepatol 2008 6 : 782 788.
20. Laboratory detection and reporting of bacteria with extended spectrum beta-lactamases. Issue no: 2.2 Issue date: 19 May 2008. Ref. no. QSOP 51i2. Available at: http://www.hpa-standardmethods.org.uk/pdf-sops.asp
21. Carter MJ, Lobo AJ, Travis SP. Guidelines for the management of inflammatory bowel disease in adults. Gut 2004 53 (Suppl 5 V1 16.
22. McLaughlin SD, Clark SK, Bell AJ, et al. An open study of antibiotics for the treatment of pre-pouch ileitis following restorative proctocolectomy with ileal pouch-anal anastomosis. Aliment Pharmacol Ther 2008 [Epub ahead of print].
23. McLaughlin SD, Clark SK, Tekkis PP, et al. An open study of maintenance antibiotic therapy for chronic antibiotic dependent pouchitis; efficacy, complications and outcome. Colorectal Dis 2009 [Epub ahead of print].
24. Johnson MW, Maestranzi S, Duffy AM, et al. Faecal calprotectin: a noninvasive diagnostic tool and marker of severity in pouchitis. Eur J Gastroenterol Hepatol 2008 20 : 174 179.
25. Gionchetti P, Rizzello F, Poggioli G, et al. Oral budesonide in the treatment of chronic refractory pouchitis. Aliment Pharmacol Ther 2007 25 : 1231 1236.
26. Sambuelli A, Boerr L, Negreira S, et al. Budesonide enema in pouchitis - a double-blind, double-dummy, controlled trial. Aliment Pharmacol Ther 2002 16 : 27 34.
27. Ferrante M, D'Haens G, Dewit O, et al. Efficacy of infliximab in refractory pouchitis and Crohn's disease-related complications of the pouch: a Belgian case series. Inflamm Bowel Dis 2010 16 : 243 249.
28. Calabrese C, Gionchetti P, Rizzello F, et al. Short-term treatment with infliximab in chronic refractory pouchitis and ileitis. Aliment Pharmacol Ther 2008 27 : 759 764.
29. Shen B, Remzi FH, Lavery IC, et al. Administration of adalimumab in the treatment of Crohn's disease of the ileal pouch. Aliment Pharmacol Ther 2009 29 : 519 526.
30. Belluzzi A, Serrani M, Roda G, et al. Pilot study: the use of sulfasalazine for the treatment of acute pouchitis. Aliment Pharmacol Ther 2010 31 : 228 232.
31. Gionchetti P, Rizzello F, Morselli C, et al. High-dose probiotics for the treatment of active pouchitis. Dis Colon Rectum 2007 50 : 2075 2082.
32. Adam B, Liebregts T, Holtmann G. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Z Gastroenterol 2006 44 : 267 269.
33. Gionchetti P, Rizzello F, Venturi A, et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 2000 119 : 305 309.
34. Mimura T, Rizzello F, Helwig U, et al. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut 2004 53 : 108 114.
35. Shen B, Brzezinski A, Fazio VW, et al. Maintenance therapy with a probiotic in antibiotic-dependent pouchitis: experience in clinical practice. Aliment Pharmacol Ther 2005 22 : 721 728.
36. Rowley S, Candinas D, Mayer AD, et al. Restorative proctocolectomy and pouch anal anastomosis for ulcerative colitis following orthotopic liver transplantation. Gut 1995 37 : 845 847.
37. Zins BJ, Sandborn WJ, Penna CR, et al. Pouchitis disease course after orthotopic liver transplantation in patients with primary sclerosing cholangitis and an ileal pouch-anal anastomosis. Am J Gastroenterol 1995 90 : 2177 2181.